As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. Pembrolizumab (Keytruda) is one of the first…
Tag: Lung Cancer Treatment
Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in some trials. In the medical…
Lung Cancer Screenings Could Detect Signs of Heart Disease via Artificial Intelligence
According to a study presented at the annual meeting of the Radiological Society of North America, artificial intelligence could measure a common marker of heart disease in patients getting chest CT scans…
Artificial Intelligence to Determine Who Will Benefit from Immunotherapy
Scientists can now determine which lung cancer patients will benefit from the expensive immunotherapy. They have previously used AI to determine the type of lung cancer. Now, according to the study published…
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of Barcelona and Hospital…
Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating awareness about this deadly disease is…
Non-Toxic Nanoscale Treatment Promises Efficient Lung Cancer Treatment
Lung Cancer is one of the most deadly diseases all around the world. No country has been escaped from it. Scientists have been working towards finding new and effective lung cancer treatments….
New Lung Cancer Treatment Approved By NHS Scotland
The Scottish Medicines Consortium (SMC) confirms another immunotherapy treatment in combination with chemotherapy drugs is to be made available on NHS for patients with advanced lung cancer. The decision has been to…